Durvalumab vs Warfarin

## Durvalumab vs Warfarin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Warfarin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Warfarin**: Inhibits vitamin K epoxide reductase complex.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Warfarin — 20-60 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Warfarin — C19H16O4.

**Molecular Weight**: Durvalumab — N/A; Warfarin — 308.3280 g/mol.

**Type**: Durvalumab — Antibody; Warfarin — Small molecule.